APIs

Evogliptin

Cat Number
API1222102295
CAS Number
1222102-29-5

If you have any other questions, please contact our experts.

CAS Number
1222102-29-5
Description
Evogliptin (DA-1229) is a DPP4 inhibitor with oral activity. Evogliptin has significant and lasting hypoglycemic effect in mouse model. Evogliptin inhibits the production of the fibrosis and inflammatory in hepatocytes signals by inducing autophagy. Evogliptin can be used to study type 2 diabetes, chronic liver inflammation, osteoporosis and renal impairment.
Molecular Formula
C19H26F3N3O3
Molecular Weight
401.42
You Might Also Like
Paroxetine hydrochloride
Paroxetine hydrochloride

Cat NO.: API78246498
CAS NO.: 78246-49-8

View Details
Alpelisib hydrochloride
Alpelisib hydrochloride

Cat NO.: API1584128915
CAS NO.: 1584128-91-5

View Details
Enzalutamide-d3
Enzalutamide-d3

Cat NO.: API1443331825
CAS NO.: 1443331-82-5

View Details
Ancitabine Hydrochloride
Ancitabine Hydrochloride

Cat NO.: API10212256
CAS NO.: 10212-25-6

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat

WhatsAPP
Top